ISC, DOAJ, CAS, Google Scholar......

Structural and Chemical Study of the Effect of Doping the Pyridine Ring on the Structure of Boron-carbon-nitrogen (BCN) Nanotubes in two Configurations: Armchair (3,3) and Zigzag (6,0)

Document Type : Research Paper

Authors

Department of Chemistry, Dezful Branch, Islamic Azad University, Dezful, Iran

Abstract
The  synthesis  processes  of  nanomaterials  have  been  rapidly  growing  and  have  made  it  possible  to 
achieve new materials such as heterogeneous structures that exhibit new and attractive phenomena and 
physical properties. To achieve desirable properties, it is necessary to chemically modify these materials. 
In  this  research,  the  structural  and  chemical  properties  of  armchair  and  zigzag  carbon  nanotubes  and 
boron-carbon-nitrogen  (BCN)  composite  nanotubes  were  first  examined,  and  the  changes  in  the 
structural and chemical properties of the boron-carbon-nitrogen (BCN) composite nanotubes due to the 
addition of pyridine were studied. The initial structure of the compounds was drawn using ChemOffice 
software.  The  optimization  of  the  structures  and  the  calculation  of  parameters  were  performed  in 
Gaussian 09 based on density functional theory calculations at the B3LYP/3-21G theoretical level. The 
results showed that boron-carbon-nitrogen composite nanotubes are more stable than carbon nanotubes, 
and doping with pyridine resulted in greater stability of the pyridine-doped composite nanotubes. Zigzag 
nanotubes are slightly more stable than armchair ones. This study shows that the stability, activity, and 
reactivity of BCN composite nanotubes have changed with doping with pyridine and under the influence 
of the structural changes made, and by altering the chemical and structural properties of BCN composite 
nanotubes,  their application  in various electrical, chemical, and medical  industries can be modified or 
improved. 

Keywords

Subjects

[1] J. R. Swanson, et al., J Forensic Sci., 42, 335 (1994). 
[2] J. C. Nelson, J Clin Psychiatry., 45, 10 (1984). 
[3] A. Ghanizadeh, Curr Drug Saf., 8, 169 (2013). 
[4] D. S. Janowsky B. Byerley J Clin Psychiatry. 45, 3 (1984).  
[5] R. O. Friedel, J Clin Psychiatry., 45, 46 (1984). 
[6] J. F. Rosenbaum, J Clin Psychiatry. 45, 17 (1984).  
[7] F. R. Sallee, Clin Pharmacokinet., 18(5), 346 (1990).  
[8] L. Hearn, et al., Cochrane Database Syst Rev., 2, 10 (2014). 
[9] D. Healy, C. Whitaker, J Psychiatry Neurosci., 28, 5 (2003). 
[10] N. Perroud, CNS Drugs., 25, 459 (2011). 
[11] Y. Wang, H. Xu, J. Zhang, G. Li, Sensors., 8, 2043 (2008). 
 [12] F. M. Alipour, etal., Int J New Chem., 10, 197 (2023). 
[13] B. J. Privett, et al., Anal Chem., 82, 4723 (2010). 
[14] R. Farahani, T. Madrakian, A. Afkhami, Int J New Chem., 9, 383 (2023).  
[15] J. Paier, M. Marsman, G. Kresse, J Chem Phys., 127, 2 (2007).  
[16] M. R. Sameti, M. B. Naghibi. Int J New Chem., 11, 15 (2023).  
[17] R. Mousavi, et al., Int J New Chem., 10, 268 (2023). 
 [18] A. E. Frisch, R. E. Plata, D. A. Singleton. Gaussian 09W Reference. J Am Chem Soc. 137, 
3811 (2009). 
[19]. Frisch M.J., Trucks G.W., Schlegel H.B., Scuseria G.E., Robb M. a., Cheeseman J.R., [1]. 
Scalmani G., Barone V.,  Petersson G.  a., Nakatsuji H.,  Li X., Caricato M., Marenich    a. V., 
Bloino J., Janesko B.G., Gomperts R., Mennucci B., Hratchian H.P., Ortiz J. V., Izmaylov  a. F, 
Sonnenberg  J.L., Williams,  Ding  F.,  Lipparini  F.,  Egidi  F.,  Goings  J.,  Peng  B.,  Petrone  A., 
Henderson T., Ranasinghe D., Zakrzewski V.G., Gao J., Rega N., Zheng G., Liang W., Hada M., 
Ehara M., Toyota K.,  Fukuda R., Hasegawa  J.,  Ishida M., Nakajima T., Honda Y., Kitao O., 
Nakai H., Vreven T., Throssell K., Montgomery J.r. J. a., Peralta J.E, Ogliaro F., Bearpark M.J., 
Heyd J.J., Brothers E.N., Kudin K.N., Staroverov V.N., Keith T. a., Kobayashi R., Normand J., 
Raghavachari K.,  Rendell    a.  P,  Burant  JC,  Iyengar  S.S.,  Tomasi  J., Cossi M., Millam  J.M., 
Klene  M.,  Adamo  C.,  Cammi  R.,  Ochterski  J.W.,  Martin  R.L.,  Morokuma  K.,  Farkas  O., 
Foresman J.B., Fox D.J. G16_C01. 2016. p. Gaussian 16, Revision C.01, Gaussian, Inc., Wallin. 
[20]. Frisch, M. J., Trucks, G. W., Schlegel, H. B., Scuseria, G. E., Robb, M. A., Cheeseman, J. 
R., ... & Fox, D. J. (2009). Gaussian 2009. Revision A, 2. 
[21] M. R. Jalali Sarvestani, R. Ahmadi, Asian J Nanosci Mater., 3, 103 (2020). 
[22] GaussView, Version 6.1, Roy Dennington, Todd A. Keith, and John M. Millam, Semichem 
Inc., Shawnee Mission, KS, (2016). 
[23] S. Melchor, J. A. Dobado, J. Chem. Inf. Comput. Sci, 44, 1639 (2004).